A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...
The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...
Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years, according to a congressional analysis. Expanding coverage of weight-loss ...
Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...
Adolescents treated with GLP1R drugs for obesity exhibit fewer suicidal thoughts, indicating potential mental health benefits ...
On this week’s episode of Economic Update: how FED Chair Jerome Powell admits capitalism’s intrinsic instability, a Tennessee plastic plant won’t let workers leave before storm Helene hits, new drugs ...